Opendata, web and dolomites

PLASREVOLUTION SIGNED

Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLASREVOLUTION project word cloud

Explore the words cloud of the PLASREVOLUTION project. It provides you a very rough idea of what is the project "PLASREVOLUTION" about.

conjugation    subsequently    plasmids    clone    medicine    transmission    chemotherapy    entail    opening    breaking    mainly    mechanisms    alleviated    plasmid    despite    central    scenarios    arrive    bacterium    patients    superbugs    microbiome    evolution    play    constricted    time    ground    molecular    dawn    clones    society    fuelled    spread    compensatory    hospitalized    bacterial    life    infectious    inappropriate    transfer    compensation    diseases    obj    genes    extensive    antibiotics    host    completely    patient    settings    uncontrollably    resistance    pivotal    era    bacteria    treatment    antibiotic    tools    first    underlying    post    coevolution    successful    cancer    basis    exploring    interventions    unexplored    contexts    genetic    pathogenic    gap    dynamics    drive    surgery    avenues    resolution    plan    ar    bridge    clinical    indispensable    horizontal    clinically    unprecedentedly    associations    modern    mediated    treatments    meeting    fitness    dynamic    gut   

Project "PLASREVOLUTION" data sheet

The following table provides information about the project.

Coordinator
SERVICIO MADRILENO DE SALUD 

Organization address
address: PLAZA CARLOS TRIAS BERTRAN 7
city: MADRID
postcode: 28020
website: http://cort.as/10Yf

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙497˙314 €
 EC max contribution 1˙497˙314 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERVICIO MADRILENO DE SALUD ES (MADRID) coordinator 1˙497˙314.00

Map

 Project objective

Antibiotics are essential tools in modern medicine and are indispensable not only for the treatment of infectious diseases but also to support other key interventions such as surgery and cancer chemotherapy. However, the extensive and inappropriate use of antibiotics has fuelled the spread of resistance mechanisms in pathogenic bacteria, leading to the dawn of a post-antibiotic era. Plasmids play a pivotal role in the evolution of antibiotic resistance (AR) because they drive the horizontal transfer of resistance genes between pathogenic bacteria by conjugation. Some of these plasmid-bacterium associations become particularly successful, creating superbugs that spread uncontrollably in clinical settings. The rise of these clones is mainly constricted because plasmids entail a fitness cost when they arrive in a new bacterial host. This cost can be subsequently alleviated through compensatory adaptation during plasmid-bacterium coevolution. Despite the importance of this cost-compensation dynamic in the evolution of plasmid-mediated AR, it remains completely unexplored in clinical contexts. In this project I plan to bridge this gap by exploring the genetic basis underlying the evolution of plasmid-mediated AR in clinically relevant scenarios. We will study, for the first time, the intra-patient transmission, fitness cost and adaptation of AR plasmids in the gut microbiome of hospitalized patients (obj. 1). We will analyse the molecular mechanisms that determine the success of AR plasmids and bacterial clone associations (obj. 2). Finally, we will develop new technology to test how antibiotic treatments affect AR plasmids dynamics in the gut microbiome at an unprecedentedly high-resolution (obj. 3). This ground-breaking project will allow a new understanding of the evolution of plasmid-mediated AR in real life, opening new research avenues and providing a major step towards meeting one of the central challenges facing our society: controlling the spread of AR.

 Publications

year authors and title journal last update
List of publications.
2019 R. Craig MacLean, Alvaro San Millan
The evolution of antibiotic resistance
published pages: 1082-1083, ISSN: 0036-8075, DOI: 10.1126/science.aax3879
Science 365/6458 2019-10-03
2018 Alvaro San Millan
Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context
published pages: , ISSN: 0966-842X, DOI: 10.1016/j.tim.2018.06.007
Trends in Microbiology monthly 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLASREVOLUTION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLASREVOLUTION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ERC VP CSA (2018)

Support to the Vice-Presidents of the ERC Scientific Council 2018

Read More  

CELPRED (2020)

Circuit elements of the cortical circuit for predictive processing

Read More  

MITOvTOXO (2020)

Understanding how mitochondria compete with Toxoplasma for nutrients to defend the host cell

Read More